{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:19Z","timestamp":1785873559564,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children Boston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.burns.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T06:04:19Z","timestamp":1616047459000},"page":"1833-1843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients"],"prefix":"10.1016","volume":"47","author":[{"given":"Asma","family":"Tchakal-Mesbahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merzak","family":"Metref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4872-4545","authenticated-orcid":false,"given":"Vijay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Almpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-4332","authenticated-orcid":false,"given":"Laurence G.","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2021.03.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.burns.2021.03.005_bib0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.burns.2021.03.005_bib0015","first-page":"675","article-title":"Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran","volume":"49","author":"Ranjbar","year":"2011","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.burns.2021.03.005_bib0020","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/AAC.00032-13","article-title":"Dissemination of a class I integron carrying VIM- 2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria","volume":"57","author":"Touati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/AAC.48.4.1175-1187.2004","article-title":"Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production","volume":"48","author":"Bagge","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.burns.2021.03.005_bib0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ps\/82.4.622","article-title":"Monitoring and identifying antibiotic resistance mechanisms in Bacteria","volume":"82","author":"Roe","year":"2003","journal-title":"Poult Sci"},{"key":"10.1016\/j.burns.2021.03.005_bib0040","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/504477","article-title":"Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa","volume":"Suppl 2","author":"Bonomo","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2334-9-123","article-title":"In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo b-lactamase-producing Pseudomonas aeruginosa","volume":"9","author":"Oie","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.burns.2021.03.005_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2014.09.029","article-title":"Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals","volume":"8","author":"Garza-Ramos","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/mdr.2013.0004","article-title":"Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals","volume":"19","author":"Vatcheva-Dobrevska","year":"2013","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.burns.2021.03.005_bib0065","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.49.9.3743-3748.2005","article-title":"BEL-1, a novel clavulanic acid-inhibited extendedspectrum \u03b2-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa","volume":"49","author":"Poirel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0070","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jac\/dkq048","article-title":"Detection and characterization of class A extended-spectrum-\u03b2-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals","volume":"65","author":"Glupczynski","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0075","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.01660-10","article-title":"PME-1, an extended-spectrum \u03b2-lactamase identified in Pseudomonas aeruginosa","volume":"55","author":"Tian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.burns.2021.03.005_bib0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.01512-08","article-title":"Diversity, epidemiology, and genetics of class D beta-lactamases","volume":"54","author":"Poirel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.burns.2021.03.005_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2014.03.007","article-title":"Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing beta-lactamases with extended-spectrum activity","volume":"79","author":"Bae","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.burns.2021.03.005_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/1040841X.2010.481763","article-title":"Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa","volume":"36","author":"Zhao","year":"2010","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"10.1016\/j.burns.2021.03.005_bib0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/mdr.2013.0161","article-title":"Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012","volume":"20","author":"Sefraoui","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.burns.2021.03.005_bib0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0110","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1128\/JCM.00997-07","article-title":"Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum b-lactamase in Warsaw, Poland: further evidence for an international clonal complex","volume":"45","author":"Empel","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.burns.2021.03.005_bib0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jmii.2011.11.015","article-title":"Phenotypic detection and polymerase chain reaction screening of extended-spectrum \u03b2-lactamases produced by Pseudomonas aeruginosa isolates","volume":"45","author":"Lin","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.burns.2021.03.005_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.medmal.2008.01.009","article-title":"Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria","volume":"38","author":"Drissi","year":"2008","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.burns.2021.03.005_bib0125","first-page":"818","article-title":"CDC definitions for nosocomial infections 1988","volume":"85","author":"Garner","year":"1991","journal-title":"Z Arztl Fortbild"},{"key":"10.1016\/j.burns.2021.03.005_bib0130","series-title":"Biochemical tests for identification of medical bacteria","author":"MacFaddin","year":"2000"},{"key":"10.1016\/j.burns.2021.03.005_bib0135","series-title":"Weissfeld A. Bailey and Scott\u2019s diagnostic. Microbiology E-book","author":"Forbes","year":"2015"},{"issue":"January (1)","key":"10.1016\/j.burns.2021.03.005_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/am.25.1.107-110.1973","article-title":"Incidence and identification of Pseudomonas fluorescens and Pseudomonas putida in the clinical laboratory","volume":"25","author":"Blazevic","year":"1973","journal-title":"Appl Microbiol"},{"issue":"December (1)","key":"10.1016\/j.burns.2021.03.005_bib0145","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12879-020-05534-1","article-title":"Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia","volume":"20","author":"Alonso","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0150","unstructured":"UK standards for microbiology investigations identification of Pseudomonas species and other non-glucose fermenters. https:\/\/assets.publishing.service.gov.uk."},{"issue":"August (8)","key":"10.1016\/j.burns.2021.03.005_bib0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1139\/m83-142","article-title":"Morphological and physiological characteristics and lipopolysaccharide composition of N2-fixing (C2H2-reducing) root-associated Pseudomonas sp","volume":"29","author":"Haahtela","year":"1983","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.burns.2021.03.005_bib0160","unstructured":"API reference guide. www.biomerieux-usa.com\/clinical\/api."},{"key":"10.1016\/j.burns.2021.03.005_bib0165","series-title":"EUCAST disk diffusion method for antimicrobial susceptibility testing. Version 6.0","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2017"},{"key":"10.1016\/j.burns.2021.03.005_bib0170","series-title":"Breakpoint tables for interpretation of MIC and zone diameters. Version 7.1","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2017"},{"key":"10.1016\/j.burns.2021.03.005_bib0175","volume":"vol. 32","author":"CLSI","year":"2012"},{"key":"10.1016\/j.burns.2021.03.005_bib0180","first-page":"8","article-title":"Detection of Ambler class A, B and D \u03b2-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients","volume":"27","author":"Hakemi Vala","year":"2014","journal-title":"Ann Burns Fire Disasters"},{"issue":"January (1)","key":"10.1016\/j.burns.2021.03.005_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/49.1.77","article-title":"Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal","volume":"49","author":"F\u00e9ria","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/mdr.2017.0102","article-title":"Prevalence of aminoglycoside-modifying enzymes in Escherichia coli and Klebsiella pneumoniae producing extended spectrum b-lactamases collected in two multicenter studies in Spain","volume":"24","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.burns.2021.03.005_bib0195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jac\/dkl055","article-title":"Spread of blaCTX-M-type and blaPER-2 genes in clinical isolates from Bolivian hospitals","volume":"57","author":"Celenza","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"June (6)","key":"10.1016\/j.burns.2021.03.005_bib0200","article-title":"Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods","volume":"12","author":"Laudy","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.burns.2021.03.005_bib0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/mdr.2010.0104","article-title":"Diversity of beta-lactamases in Pseudomonas aeruginosa isolates producing metallo-beta-lactamase in two Tunisian hospitals","volume":"17","author":"Ktari","year":"2011","journal-title":"Microb Drug Resist"},{"issue":"8","key":"10.1016\/j.burns.2021.03.005_bib0210","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1128\/AAC.01646-09","article-title":"Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France","volume":"54","author":"Hocquet","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.burns.2021.03.005_bib0215","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/JCM.39.5.1865-1870.2001","article-title":"Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase","volume":"39","author":"Luzzaro","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.burns.2021.03.005_bib0220","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1128\/JCM.42.6.2523-2529.2004","article-title":"Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy","volume":"42","author":"Pagani","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.burns.2021.03.005_bib0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jac\/dkr471","article-title":"Detection of Pseudomonas aeruginosa isolates of the international clonal complex 11 carrying the blaPER-1 extended-spectrum \u03b2-lactamase gene in Greece","volume":"67","author":"Ranellou","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.burns.2021.03.005_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.femsle.2005.06.012","article-title":"PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp","volume":"249","author":"Kolayli","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.burns.2021.03.005_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-0711-7-12","article-title":"Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary","volume":"7","author":"Szab\u00f3","year":"2008","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"12","key":"10.1016\/j.burns.2021.03.005_bib0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ja.2006.104","article-title":"Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem","volume":"59","author":"Yamano","year":"2006","journal-title":"J Antibiot (Tokyo)"},{"issue":"July\u2013September (3)","key":"10.1016\/j.burns.2021.03.005_bib0245","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/ijmm.IJMM_18_294","article-title":"Dominance of international high-risk clones in carbapenemase-producing Pseudomonas aeruginosa: multicentric molecular epidemiology report from India","volume":"36","author":"Pragasam","year":"2018","journal-title":"Indian J Med Microbiol"},{"issue":"8","key":"10.1016\/j.burns.2021.03.005_bib0250","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.18352v2","article-title":"Class A and D extended-spectrum \u03b2-lactamases in imipenem resistant Pseudomonas aeruginosa isolated from burn patients in Iran","volume":"8","author":"Pakbaten Toupkanlou","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.burns.2021.03.005_bib0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jgar.2018.09.008","article-title":"First report of Pseudomonas aeruginosa co-harbouring blaVIM-2 and blaPER-1 in Latin America","volume":"15","author":"Papa-Ezdra","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"10.1016\/j.burns.2021.03.005_bib0260","first-page":"19400","article-title":"Prevalence of ESBLs-producing Pseudomonas aeruginosa isolates from different wards in a Chinese teaching hospital","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"10.1016\/j.burns.2021.03.005_bib0265","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1128\/AAC.01602-08","article-title":"Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa","volume":"53","author":"Pic\u00e3o","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.burns.2021.03.005_bib0270","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2334-12-176","article-title":"Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital","volume":"12","author":"Polotto","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.burns.2021.03.005_bib0275","article-title":"Molecular study of the prevalence of CTX-M1, CTX-M2, CTXM3 in Pseudomonas aeruginosa isolated from clinical samples in Tabriz Town, Iran","volume":"13","author":"Sales","year":"2017","journal-title":"Electron J Biol"},{"key":"10.1016\/j.burns.2021.03.005_bib0280","first-page":"1479","article-title":"Epidemiological and antibiotic resistant study on extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province","volume":"115","author":"Yu","year":"2002","journal-title":"Chin Med J"},{"key":"10.1016\/j.burns.2021.03.005_bib0285","first-page":"4885","article-title":"Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria","author":"Meradji","year":"2016","journal-title":"Burns"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T08:15:55Z","timestamp":1759652155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417921000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0305417921000759"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2021.03.005","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}